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Crossregulation between Neurogenin2
and Pathways Specifying Neuronal
Identity in the Spinal Cord
subsequently by the floor plate (reviewed in Jessell,
2000). Shh acts in a concentration-dependent manner
to both induce the expression of some homeodomain
proteins (e.g., Nkx2.2 and Nkx6.1) and repress that of
others (e.g., Pax6, Irx3, Dbx2). The expression of specific
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combinations of homeodomain proteins at different DVB.P. 163
levels of the neural tube results in the establishment of67404 Illkirch Ce´dex
distinct progenitor domains which give rise to particularC.U. de Strasbourg
classes of neurons. The function of these early ex-France
pressed homeodomain proteins in specifying neuronal
fates is thought to be relayed through the action of
another set of homeodomain proteins that are ex-Summary
pressed by progenitor cells as they exit the cell cycle
and begin to differentiate (Briscoe et al., 2000; Jessell,We have examined how genetic pathways that specify
2000). Among these are MNR2 and Hb9, two relatedneuronal identity and regulate neurogenesis interface
factors that have been implicated in the specification ofin the vertebrate neural tube. Here, we demonstrate
MN identity in chick (Tanabe et al., 1998) and in mousethat expression of the proneural gene Neurogenin2
(Arber et al., 1999; Thaler et al., 1999), and Lim3, which(Ngn2) in the ventral spinal cord results from the modu-
is involved in the specification of V2 interneurons andlar activity of three enhancers active in distinct progen-
a subtype of MNs (Sharma et al., 1998).itor domains, suggesting that Ngn2 expression is con-
Members of the basic helix-loop-helix (bHLH) classtrolled by dorsoventral patterning signals. Consistent
of transcription factors play essential roles in lineagewith this hypothesis, Ngn2 enhancer activity is depen-
determination and in the differentiation of neural progen-dent on the function of Pax6, a homeodomain fac-
itors (Kageyama and Nakanishi, 1997; Guillemot, 1999).tor involved in specifying the identity of ventral spinal
Pioneering studies in Drosophila have demonstratedcord progenitors. Moreover, we show that Ngn2 is re-
that proneural genes of the achaete-scute complex andquired for the correct expression of Pax6 and several
atonal confer neural competence to ectodermal cellshomeodomain proteins expressed in defined neuronal
and control the selection of individual neural precursorspopulations. Thus, neuronal differentiation involves
from clusters of initially equivalent cells (Jan and Jan,crossregulatory interactions between a bHLH-driven
1994). Loss- and gain-of-function studies have providedprogram of neurogenesis and genetic pathways speci-
evidence that vertebrate homologs of the fly proneuralfying progenitor and neuronal identity in the spinal
genes function in a similar manner. For example, thecord.
murine achaete-scute homolog Mash1 is required for
the generation of neural progenitors in the ventral fore-Introduction
brain and olfactory epithelium (Cau et al., 1997; Casa-
rosa et al., 1999). Similarly, the atonal-related genesProgenitor populations located in different regions of the
Neurogenin1 (Ngn1) and Neurogenin2 (Ngn2) are re-neural tube undergo distinct programs of neurogenesis,
quired for the generation of progenitors of cranial sen-giving rise to specific neuronal subtypes at precise de-
sory ganglia (Fode et al., 1998; Ma et al., 1998), whilevelopmental times (McConnell, 1995). The molecular
the atonal ortholog Math1 is required for the generation
pathways that control the generation and differentiation
of cerebellar granular cells (Ben-Arie et al., 1997).
of neurons and the specification of their identity are
In addition to these early functions in the determina-
starting to be unraveled (Edlund and Jessell, 1999). It tion of neural lineages, proneural genes have been impli-
remains unclear, however, how these pathways are inte- cated in the specification of neuronal phenotypes in
grated to yield the highly diverse and reproducible pat- both Drosophila and vertebrates (Jan and Jan, 1994;
terns of neuronal differentiation that characterize the Jarman and Ahmed, 1998; Brunet and Ghysen, 1999;
developing neural tube (Tanabe and Jessell, 1996; An- Guillemot, 1999). In vertebrates, Mash1, Math1, and the
derson and Jan, 1997). Ngns are expressed in largely nonoverlapping popula-
The question of how different classes of neurons are tions of progenitor cells that give rise to different types
generated at distinct positions in the nervous system of neurons. In the peripheral nervous system (PNS),
has been best addressed in the ventral spinal cord Mash1 is expressed in progenitors of autonomic neu-
(Briscoe et al., 2000). Motor neurons (MNs) and in- rons where it controls the acquisition of a noradrenergic
terneurons are derived from progenitor cell populations neurotransmission phenotype. This occurs through the
located at defined positions along the dorsoventral (DV) regulation by Mash1 of the expression of Phox2a, a
axis of the neural tube. The DV identity of progenitor homeodomain protein that controls noradrenergic dif-
cells in the ventral spinal cord is specified in response ferentiation by directly regulating the expression of the
to graded concentrations of Sonic hedgehog (Shh), a catecholamine biosynthetic enzymes tyrosine hydroxy-
morphogen that is secreted first by the notochord and lase and dopamine -hydroxylase (Lo et al., 1997; Hirsch
et al., 1998; Goridis and Brunet, 1999). Expression of
the Ngns in the PNS is complementary to that of Mash11Correspondence: francois@igbmc.u-strasbg.fr
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and is restricted to sensory neuron progenitors. A role Results
for the Ngns in the specification of sensory neuron phe-
Analysis of Ngn2 cis-Regulatory Elementsnotypes has been proposed based on forced expression
in Transgenic Miceexperiments in chicken embryos that result in the ec-
We have initiated a study of the mechanisms regulatingtopic expression of sensory neuron-specific markers in
the expression of Ngn2, with the goal of identifying regu-neural and mesodermal cells (Perez et al., 1999). Mash1
latory pathways responsible for the spatial and temporaland the Ngns are also expressed in a complementary
control of neurogenesis. As a first step toward the identi-manner in the CNS (Sommer et al., 1996; Fode et al.,
fication of Ngn2 regulatory sequences, we sequenced2000). In the forebrain, Mash1 is expressed at higher
a 16.5 kb genomic clone that included the 792 bp openlevels in ventral progenitors, and when misexpressed
reading frame of Ngn2, 9.2 kb of 5 sequence, and 6.5dorsally, it induces the ectopic expression of ventral-
kb of 3 sequence (Figure 1A).specific genes such as GAD67, which encodes for a
The conservation across species of noncoding se-biosynthetic enzyme for the neurotransmitter GABA
quences in the vicinity of a gene frequently marks the(Fode et al., 2000). These studies thus strongly suggest
presence of regulatory elements. We thus compared thethat the expression of distinct bHLH genes in different
genomic sequences of mouse and human Ngn2 (seeprogenitor populations leads to the diversification of
Experimental Procedures). The translated regions of theneuronal types. The control of bHLH gene expression
mouse and human genes show 87% similarity. A numberis therefore an important step in the process of cell type
of clusters of remarkably high nucleotide sequence con-specification in the nervous system.
servation (81% to 94%) were also found outside theIn the spinal cord, the ventricular zone can be subdi-
coding region (Figure 1A). These conserved domainsvided into a number of discrete DV domains based on
cover a total of 3.8 kb and are scattered throughout theexpression of bHLH genes. For example, Ngn3 is ex-
16.5 kb of genomic sequence we analyzed, suggestingpressed in a ventral domain adjacent to the floor plate,
that elements involved in Ngn2 regulation may be lo-Ngn1 and Ngn2 are expressed throughout most of the
cated both 5 and 3 of the gene.basal plate, Mash1 is expressed in a large part of the
To begin to characterize the cis-regulatory elementsalar plate, and Math1 is expressed in a dorsal domain
controlling the expression of Ngn2 in the embryonic
adjacent to the roof plate (Gradwohl et al., 1996; Sommer
nervous system, we subcloned Ngn2 genomic DNA into
et al., 1996; Tanabe and Jessell, 1996; Helms et al.,
four fragments, designated E1 to E4, each containing
2000). The mechanisms by which bHLH gene expression
different blocks of conserved sequences (Figure 1A).
is restricted along the DV axis of the neural tube and The fragments were inserted either 5 (for E1 and E3) or
the question of whether the restricted expression of 3 (for E4) of the basal promoter for hsp68 (Kothary et
bHLH factors reflects a role for these genes in the speci- al., 1989) or human -globin (Yee and Rigby, 1993) fused
fication of distinct neuronal fates have not yet been to the LacZ reporter gene. The E2 fragment, which con-
examined. Thus, despite mounting evidence that bHLH tains the endogenous promoter, was cloned directly up-
genes are important players in the specification of neu- stream of the LacZ gene, using an IRES sequence to
ronal identities, the question of whether and how these initiate LacZ translation (Figure 1B). Figure 2 shows the
genes interact with other genetic pathways implicated patterns of LacZ expression obtained with the different
in neuronal subtype specification in the spinal cord re- constructs in transgenic embryos at E10.5, along with
mains to be addressed. an embryo carrying a LacZ knockin allele of Ngn2 for a
To begin to examine how proneural genes contribute direct comparison with endogenous Ngn2 expression
to neuronal phenotype specification, we initiated a study (Ngn2KILacZ ; Fode et al., 2000). The four Ngn2 genomic
of the regulation and function of Ngn2 in the ventral fragments have robust enhancer activities and drive
spinal cord. We show here that Ngn2 expression in this LacZ expression in different subregions of the endoge-
region of the neural tube results from the modular activ- nous Ngn2 expression domain in both brain and spinal
ity of at least three enhancers that are active in distinct cord, with limited ectopic activity and no significant vari-
DV domains, suggesting that Ngn2 expression is con- ations between embryos with different transgene inser-
trolled by signals providing positional information to spi- tion sites (Figure 1B). A more detailed analysis of the
nal cord progenitors. Consistent with this idea, Ngn2 activities of the four enhancers is reported below.
expression and enhancer activities are disrupted in mice
carrying a mutation in Pax6, which present DV patterning Patterns of LacZ Expression in Transgenic Embryos
defects in the spinal cord (Ericson et al., 1997). More- An identical pattern of -gal activity was observed in all
over, interactions between Ngn2 and the regulatory E1::LacZ transgenic embryos examined at E10.5 (8/8
pathways underlying neural tube patterning are bidirec- independent insertions; Figure 1B), which included a
tional, as embryos mutant for Ngn2 display striking de- ventral domain extending from the caudal spinal cord
fects in the expression of several homeodomain proteins to the rostral hindbrain, dorsal regions of the caudal
expressed in progenitors and restricted neuronal popu- diencephalon, and the lateral-most portion of the dorsal
lations in the ventral spinal cord. Our data thus provide telencephalon (Figure 2B). X-gal staining of E10.5 em-
evidence for complex crosstalks between pathways of bryos carrying the E2::LacZ transgene labeled a ventral
neurogenesis and DV patterning in the spinal cord and domain along the entire length of the spinal cord, hind-
place Ngn2 in a central position where it is both respon- brain, and caudal mesencephalon (6/6; Figures 1B and
sive to and a regulator of genetic pathways that provide 2C). Embryos with the E3::LacZ transgene showed a
pattern of -gal activity that included ventral and dorsalpositional identity and specify neuronal fates.
Ngn2 and Homeodomain Genes in Ventral Neural Tube
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Figure 1. Analysis of Ngn2 Regulatory Sequences
(A) Diagram of the Ngn2 locus (open box) representing the Ngn2 coding sequence (dark gray box), the intron in the 5UT (light gray box), and
blocks of conserved sequences between the human and mouse Ngn2 loci (vertical bars above the locus). The number and percentage of
conserved nucleotides are shown above each block. The position of the four fragments (E1–E4) used to analyze enhancer activity in the Ngn2
region is indicated. Scale bar  1 kb. N, NotI; E, EagI; X, XbaI; B, BamHI.
(B) Transgenic constructs used to study the enhancer activity of the fragments E1 to E4. The activity of E1, E2, and E3 has been analyzed in
both founder embryos and established lines, while E4 has only been analyzed in founders. Both transgenic lines and founder embryos are
counted as independent insertions. The number of embryos showing -gal activity, and the number of embryos showing the same pattern
of activity, are indicated.
domains running the length of the spinal cord and the (data not shown). A stable transgenic line was not ob-
tained for the E4::LacZ construct.hindbrain, and a broad domain in the mesencephalon
(4/4; Figures 1B and 2D). E4::LacZ transgenic embryos The four enhancers that we have defined failed to drive
LacZ expression in the PNS, where Ngn2 is expressed inshowed LacZ expression in the diencephalon, and two
out of three embryos also showed expression in a nar- the dorsal root ganglia (DRG) and epibranchial placodes
(Fode et al., 1998). In contrast, these enhancers driverow stripe in the ventral spinal cord and hindbrain, and
in a broad region of the dorsal hindbrain (Figures 1B reporter gene expression in essentially the entire endog-
enous Ngn2 domain in the CNS. To begin to examineand 2E). With the exception of ectopic -gal activity
in the rostral hindbrain and dorsal mesencephalon in the signals that may regulate Ngn2 expression, we fo-
cused our attention on the activities of the enhancersE3::LacZ and E4::LacZ transgenic embryos, all four en-
hancers drove -gal expression in regions of the neural in the ventral spinal cord.
tube that were also expressing -gal in Ngn2KILacZ em-
bryos (Figure 2A). Ngn2 Enhancers Are Active in Distinct DV
Domains of the Spinal CordThe E1, E2, and E3 transgenes were transmitted to
the germline, and embryos carrying stable insertions The four Ngn2 enhancers examined drive LacZ expres-
sion in the ventral spinal cord and ventral hindbrainwere examined at different developmental stages, re-
vealing that the onset of all three enhancer activities (Figures 2B–2E). This suggested that these enhancers
are either redundant, active in different populations ofparallels that of endogenous Ngn2, with expression first
detected in the ventral spinal cord and hindbrain at E8.5 ventral spinal cord progenitors, or active in cells at differ-
Neuron
206
Figure 2. Activity of Ngn2 Enhancers in Different Dorsoventral Domains of the Spinal Cord
Whole-mount X-gal staining of E10.5 embryos carrying (A) the Ngn2KILacZ allele (KI) and (B–E) the E1–E4 transgenes described in Figure 1. The
four fragments of the Ngn2 locus tested have transcriptional enhancer activity. Each enhancer is active in only a portion of the Ngn2 expression
domain, but all function in the ventral spinal cord (arrows in [B]–[E]). E3 has ectopic activity in the rostral hindbrain and dorsal mesencephalon,
and E4 has ectopic activity in the rostral hindbrain (* in [D] and [E]). X-gal staining of vibratome sections at brachial spinal cord level in E10.5
embryos carrying the Ngn2 KI allele (F) or the transgenes indicated below the panels (G–J). Endogenous Ngn2 is expressed in broad domains
in the ventral and dorsal spinal cord, as indicated by LacZ expression from the Ngn2KILacZ allele (F). Each of the four Ngn2 enhancers is active
in a different ventral domain of the spinal cord (G–J), while E3 is also active dorsally (I). -gal activity is higher in the VZ of E1–E4::LacZ embryos
as compared with the VZ of Ngn2KILacZ embryos, possibly due to higher expression levels of the transgenes. Double immunocytochemical labeling
for -gal (green) and GFP (red) of brachial spinal cord sections from E10.5 embryos carrying the transgenes E1::LacZ and E2::GFP (K), and
E2::GFP and E3::LacZ (L). The activity of the E1 and E2 enhancers (K) and of the E2 and E3 enhancers (L) overlap in a few cells which appear
yellow (arrowheads). (M–Q) In situ hybridization of a Ngn2 RNA probe (M) and a LacZ RNA probe (N–Q) on cryostat sections of the spinal
cord of E10.5 wild-type (WT) and transgenic embryos, as indicated. LacZ transcripts are restricted to VZ progenitors in E1, E2, and E3
transgenic embryos (O–Q) as for Ngn2 transcript (M) and for LacZ transcripts in Ngn2KILacZ embryos (N). The detection of X-gal staining of the
mantle zone in Ngn2KILacZ and transgenic embryos (F–J) is thus due to the perdurance of the -gal protein in post mitotic cells which have
stopped transcribing Ngn2.
ent stages of maturation. To distinguish between these expression is not detected in the ventral limit of the
spinal cord in Ngn2KILacZ embryos (Figure 2F), this site inhypotheses, the spinal cord of transgenic embryos was
sectioned transversally. A comparison of sections at the E3 domain appears to be ectopic (see below). Finally,
the E4 enhancer drives reporter expression in a ventralbrachial levels showed that the four enhancers drive
LacZ expression in transverse domains of the spinal stripe of cells that corresponds to a portion of the E2
domain (Figure 2J). Hence, the addition of the E1, E2,cord that are located at different positions along the DV
axis and are flanked by sharp borders (Figures 2F–2J). and E3 enhancer domains recapitulates the expression
pattern of Ngn2 in the ventral spinal cord, with the ex-The E1 transgene is active in the dorsal-most part of the
ventral spinal cord (Figure 2G), E2 is active immediately ception of ectopic activity of E3 in the ventral-most re-
gion (Figure 2G). We thus focused on these three en-ventral to the E1 domain (Figure 2H), and the E3 expres-
sion domain includes a broad dorsal area, and the ven- hancers for the remainder of our study.
In order to more precisely determine the extent totral-most region of the spinal cord (Figure 2I). As LacZ
Ngn2 and Homeodomain Genes in Ventral Neural Tube
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which the Ngn2 enhancers drive expression in overlap- four nuclear proteins that mark distinct neuronal sub-
types in the ventral spinal cord, namely Engrailed1 (En1),ping cell populations, we generated a transgenic mouse
strain in which the E2 enhancer drives expression of the Lim3, Islet1 (Isl1), and Hb9 (red signals in Figures 3K–3Y).
Double labeling of -gal and En1, which marks V1 in-GFP reporter gene. The pattern of activity of the E2
enhancer was identical with either GFP or LacZ (data terneurons (Matise and Joyner, 1997; Figure 3K), re-
vealed that all En1 neurons are -gal in E1::LacZnot shown). We thus crossed E2::GFP mice with the
E1::LacZ and E3::LacZ strains and performed double embryos (Figure 3M), whereas only very few are -gal
in E2::LacZ embryos (Figure 3N), and no neurons arelabeling experiments on the spinal cord of embryos car-
rying two transgenes. These experiments revealed that double labeled in E3::LacZ embryos (Figure 30). Thus,
E1 is active in V1 interneuron progenitors, E2 is activethe E1 and E2 domains overlap partially, with a subset
of cells coexpressing -gal and GFP in the ventral-most in cells located just ventral to these progenitors, and E3
is active in cells located further ventrally (see summaryE1 domain and dorsal-most E2 domain (Figure 2K). Simi-
larly, a subpopulation of cells coexpressing the two re- scheme in Figure 4). In addition, -gal cells are found
dorsal to En1 neurons in E1::LacZ embryos (Figureporters was found in embryos carrying both E2::GFP
and E3::LacZ transgenes (Figure 2L). Thus, the E1, E2, 3M), a staining pattern also found in Ngn2KILacZ embryos
(Figure 3L).and E3 enhancers are active in different but partially
overlapping domains along the DV axis of the neural Lim3 is expressed by progenitors of V2 interneurons
and MNs and its expression is maintained in V2 in-tube.
In enhancer::LacZ embryos and Ngn2KILacZ embryos, terneurons, which are located ventral to the V1 popula-
tion (Sharma et al., 1998; Briscoe et al., 2000). In con--gal activity was detected in both progenitor cells in
the ventricular zone (VZ) and postmitotic cells in the trast, Isl1 is expressed only by MNs (Ericson et al., 1997).
Double labeling showed that in E1::LacZ embryos, -galmantle zone (MZ) (Figures 2F–2J), whereas Ngn2 tran-
scripts are only found in VZ progenitor cells (Figure 2M; is expressed in a dorsally located subset of Lim3 cells
(Figure 3R), and not in Isl1 cells (Figure 3W). The E1Gradwohl et al., 1996; Sommer et al., 1996). This discrep-
ancy is most likely due to the higher stability of the enhancer is therefore active in progenitors of V2 in-
terneurons (Lim3, Isl1) and not in progenitors of MNs-galactosidase protein as compared to Ngn2 tran-
scripts. Indeed, LacZ transcripts were restricted to the (Lim3, Isl1) (Figure 4). In E2::LacZ embryos, X-gal
staining is detected in nearly all Lim3 cells (Figure 3S)VZ in embryos carrying the Ngn2KILacZ allele or the en-
hancer::LacZ transgenes (Figures 2N–2Q). We thus con- and Isl1 cells (Figure 3X), indicating that E2 is active
in progenitors of V2 interneurons and MNs (Figure 4).clude that Ngn2 enhancers are primarily activated in
spinal cord progenitors. In E3::LacZ embryos, -gal is expressed in a ventrally
located subset of Lim3 cells (Figure 3T) and in all Isl1
cells (Figure 3Y). The dorsal limits of -gal expressionNgn2 Enhancers Are Active in Different
(green in Figure 3Y) and of Isl1 expression (red in FigurePopulations of Spinal Cord Progenitors
3Y) in the neural tube appear to coincide, suggestingThe expression of a number of homeodomain proteins
that E3 is active in progenitors of MNs but not V2 in-has been used to define distinct progenitor and neuronal
terneurons (Figure 4). In addition, expression of -galpopulations along the DV axis of the ventral spinal cord
in a large fraction of Nkx2.2 progenitors (Figure 3J)(Tanabe and Jessell, 1996; Briscoe et al., 2000). We used
indicates that E3 is also active in a subset of ventrallythe expression of some of these proteins to characterize
located V3 interneuron progenitors (Briscoe et al., 1999;the identity of the progenitor populations in which the
Figure 4). Double labeling of the different transgenicNgn2 enhancers are active (Figure 3). The distribution
spinal cords with -gal and Hb9, a protein expressedof the -gal reporter (green cytoplasmic signal in Figure
by MNs and their progenitors (Arber et al., 1999; Thaler3) was first compared with the expression of Pax6 and
et al., 1999), confirmed the results obtained with Isl1Nkx2.2, two homeodomain proteins present in different
(data not shown).populations of ventral spinal cord progenitors (Ericson
Figure 4 summarizes the results reported above. Ouret al., 1997; Briscoe et al., 1999; red nuclear signals in
data indicate that the solid expression of Ngn2 in theFigures 3A–3J). Pax6 is distributed in a decreasing dor-
ventral spinal cord results from the modular activity ofsal to ventral gradient in the basal plate of the spinal
at least three different enhancers. These enhancers arecord, with no expression detected in the ventral-most
active at different DV levels in partially overlapping pro-part of the neural tube (Figure 3A). Nkx2.2 expression
genitor populations. The E1 enhancer drives Ngn2 ex-is restricted to the ventral Pax6-negative domain (Figure
pression in V1 and V2 interneuron progenitors, E2 is3F). Double labeling for -gal and Pax6 showed that E1
active in progenitors for V2 interneurons and MNs, andenhancer activity is restricted to cells expressing high
E3 is active in a third and more ventral domain corre-to medium levels of Pax6 (Figure 3C), E2 is active in
sponding to progenitors for MNs and a subset of V3cells expressing medium to low levels of Pax6 (Figure
interneurons. Some of this activity is ectopic since en-3D) and not expressing Nkx2.2 (Figure 3I), and E3 is
dogenous Ngn2 expression is found only at low levelsactive in cells with low Pax6 expression (Figure 3E ) as
in a few Nkx2.2 V3 progenitor cells (arrowheads inwell as in a subset of Nkx2.2-expressing cells (Fig-
Figure 3G).ure 3J).
To further characterize the progenitor populations in
which Ngn2 enhancers are active, we examined the Pax6 Function Is Required for the Activity
of Several Ngn2 Enhancerstypes of neurons that these progenitors give rise to by
using the -gal protein as a short-term lineage tracer. The above results suggested that expression of Ngn2
in the ventral spinal cord is established in a modularWe compared -gal expression with the expression of
Neuron
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Figure 3. Ngn2 Enhancers Direct LacZ Expression in Different Populations of Progenitors and Neurons in the Ventral Spinal Cord
Ventral quadrants of brachial spinal cord from E10.5 transgenic embryos as indicated above the panels were double labeled using antibodies
for -gal and for the progenitor markers Pax6 (B–E) and Nkx2.2 (G–J), and the neuronal markers En1 (L–O), Lim3 (Q–T), and Islet 1 (V–Y). The
boxes in the left panels indicate the region magnified in the next panel. -gal staining in green is cytoplasmic while the markers stained in
red are homeodomain proteins localized to the nucleus. Double-labeled cells are indicated by arrowheads.-gal expressed from the endogenous
Ngn2 locus is found in Pax6 progenitors (B) and a few Nkx2.2 progenitors (G, arrowheads in the inset), and in En1 (L), Lim3 (Q), and
Isl1 (V) neurons. E1 directs LacZ expression in progenitors expressing high levels of Pax6 (C) and giving rise to En1 (M) and Lim3 (R)
neurons and to neurons dorsal to En1 cells (M), while E2 directs LacZ expression in cells expressing medium to low Pax6 levels (D) and
generating Lim3 (S) and Isl1 (X) neurons. Finally, E3 drives LacZ expression in cells expressing low Pax6 (E) or Nkx2.2 (J), and generating
Lim3 (T) and Isl1 (Y) neurons, and neurons ventral to Isl1 cells (Y).
fashion, involving the use of enhancer elements that tants; Ericson et al., 1997; Figure 5). In homozygous
Sey embryos carrying one copy of the Ngn2KILacZ allele,respond to signals providing DV positional identity to
progenitors. Strikingly, these enhancers are active in expression of Ngn2, monitored by -gal activity, was
markedly reduced in different regions of the nervouspopulations of progenitors expressing different levels
of the Pax6 protein (Figures 3 and 4), suggesting that system including the spinal cord, demonstrating that
Ngn2 regulation is dependent on Pax6 function (Figurestheir activity may depend on Pax6 function. To test this
hypothesis, we examined the expression of Ngn2 and 5A and 5A). Transverse sections through the spinal cord
showed that at all rostro-caudal levels, loss of Pax6the activity of the individual Ngn2 enhancers in mice
carrying a spontaneous null mutation in Pax6 (Sey mu- function results in the complete elimination of the dorsal
Ngn2 and Homeodomain Genes in Ventral Neural Tube
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Figure 4. Summary Diagram of the Domains of Activity of Ngn2 Enhancers in the Ventral Spinal Cord
The E1, E2, and E3 enhancers direct LacZ expression in distinct and partially overlapping DV progenitor domains of the spinal cord. The E1
enhancer is active in progenitors for V1 and V2 interneurons and neurons dorsal to V1, E2 in progenitors for V2 interneurons and MNs, and
E3 is active in progenitors for MNs and a subset of V3 interneurons. E3 activity in V3 interneuron progenitors appears to be largely ectopic,
as there is only very limited endogenous Ngn2 expression in this domain.
expression of Ngn2 and in a reduction of the dorsal et al., 2000; Figure 6 and data not shown). In E10.5
homozygous Ngn2KILacZ embryos, the expression do-extent of the ventral Ngn2 domain (Figure 5B and data
not shown). mains of Pax7, Nkx6.1, and Irx3 appeared unaffected
(Figures 6D, 6D, 6E, 6E, and data not shown). TheAnalysis of Ngn2 enhancer activity in the Sey mutant
background revealed that each of the spinal cord en- expression pattern of Pax6 was, however, severely al-
tered. Pax6 is normally expressed at a low level dorsally,hancers is differentially affected by the loss of Pax6
function. E1 enhancer activity was most severely af- at a high level in a medial domain, and in a decreasing
concentration gradient from medial to ventral positionsfected, with almost no X-gal staining remaining in the
ventral spinal cord in Sey mutants, while ectopic dorsal (Figure 6B). In the Ngn2 mutant spinal cord, Pax6 ex-
pression was very reduced dorsally and remained only instaining was found at brachial levels (Figures 5C and
5D). E2 enhancer activity was less affected by the Pax6 a narrow band of highly expressing cells medioventrally
(Figure 6B). A similar reduction in Pax6 expression wasmutation, with reduced levels ventrally and ectopic ex-
pression giving rise to an expanded dorsal domain (Fig- observed in the spinal cord of three out of four Ngn2
mutant embryos examined (data not shown). Interest-ures 5E and 5F). Finally, E3 enhancer activity was
greatly diminished in the dorsal spinal cord of Sey mu- ingly, expression of Pax6 was much less disturbed in
the spinal cord of E9.5 Ngn2 mutant embryos than attants, whereas activity was expanded ventrally (Figures
5G and 5H). Pax6 function is thus required to activate E10.5 (Figures 6A and 6A), suggesting that Ngn2 may
be involved in the maintenance rather than the initiationthe E1 and E3 enhancers in the ventral and dorsal spinal
cord, respectively, and to modulate the activity levels of Pax6 expression. Expression of Nkx2.2 was also af-
fected in Ngn2 mutants at E10.5, with fewer expressingof E2 and E3 ventrally, demonstrating that Pax6 has
an essential role in regulating the activity of the three cells detected in the ventral domain and a few cells
observed in ectopic positions (Figures 6C and 6C).enhancers examined. The observation that the Ngn2
enhancers, but not the Ngn2KILacZ allele, are ectopically Thus, Ngn2 function is required for the correct expres-
sion of a subset of homeodomain proteins in ventralactivated in the Sey mutant background (5B, C, 5F,
and 5H) suggests that these enhancers contain Pax6- spinal cord progenitors.
dependent repressive elements and are lacking other
negative regulatory sequences which are present in the Alterations in the Expression of Several
endogenous Ngn2 locus. Altogether, our results demon- Homeodomain Proteins in Ngn2
strate that Pax6 regulates Ngn2 expression in the spinal Mutant Spinal Cord
cord by controlling distinct enhancer elements that are We next examined whether the different classes of ven-
active at different positions along the DV axis. tral neurons were correctly specified in the absence of
Ngn2 function by studying expression of the homeodo-
main proteins Lim3, Hb9, Isl1, Lim1/2, En1, and Chx10Ngn2 Is Required for the Maintenance of Pax6
Expression in the Spinal Cord (Briscoe et al., 2000).
Lim1/2, En1, and Chx10 mark different populations ofNeural bHLH genes, including Ngn2, have been impli-
cated in the specification of neuronal fates in different spinal cord interneurons. At E10.5, Lim1/2 is normally
expressed in dorsal interneurons and V0 and V1 in-regions of the nervous system (see Introduction). We
thus asked whether Ngn2 is involved in the specification terneurons in wild-type embryos (Pierani et al., 1999;
Figure 7A). In striking contrast, Lim1/2 was expressedof the identity of certain populations of spinal cord neu-
rons. To address this issue, we examined if the expres- in only a few cells in the dorsal part of the ventral spinal
cord in Ngn2 mutants (Figure 7A). Expression of En1,sion of regulatory proteins marking specific progenitor
subpopulations and neuronal subtypes was affected in which specifically marks V1 interneurons, was also al-
most completely abolished in the mutant spinal cordthe spinal cord of Ngn2 mutant mice.
We first examined progenitor identity in the Ngn2 mu- (Figures 7B and 7B), and the number of Chx10-express-
ing V2 interneurons was also strikingly reduced (Figurestant spinal cord by studying Pax6, Pax7, and Nkx2.2
protein levels, and Nkx6.1 and Irx3 transcripts (Briscoe 7C and 7C).
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Figure 5. Pax6 Is Required for Ngn2 Enhancer Activity in the Spinal Cord
-gal activity in E10.5 embryos carrying a Ngn2KILacZ allele in a wild-type (A) and a Pax6 mutant background (A). Transverse sections through
the same embryos at cranial level (B and B). Ngn2 expression is missing from the spinal cord, hindbrain, and dorsal telencephalon in the
Sey mutant embryo (arrowhead in [A]). In the spinal cord, the dorsal domain and the dorsal-most part of the ventral domain of Ngn2 expression
are particularly affected (arrowheads in [B]). LacZ expression from the E1::LacZ transgene in wild-type (C) and Sey mutant backgrounds (C’)
at E10.5. Transverse sections of the same embryos at cranial level (D and D). E1 enhancer activity is missing from the ventral spinal cord,
dorsal telencephalon, and caudal diencephalon of Pax6 mutants (full arrowheads in [C] and [D]), while E1 is activated ectopically in the
dorsal spinal cord at brachial level (empty arrowhead in [C]). LacZ expression from the E2::LacZ transgene in wild-type (E and F) and Sey
mutant (E and F) backgrounds at E10.5. In the absence of Pax6, E2 enhancer activity is reduced in the ventral spinal cord (full arrowhead
in [E] and [F]) and is ectopically activated dorsally (empty arrowhead in [F]). LacZ expression from the E3::LacZ transgene in wild-type (G
and H) and Sey (G and H) mutant backgrounds at E10.5. There is a reduction of E3 enhancer activity in the dorsal spinal cord (full arrowhead
in [G] and [H]) and an expansion of its activity ventrally (empty arrowhead in [H]). The arrow in (A) indicates the level of the transverse spinal
cord sections.
Ngn2 and Homeodomain Genes in Ventral Neural Tube
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Figure 6. Ngn2 Is Required for Correct Spinal Cord Expression of Pax6 and Nkx2.2
(A–E and A–E) Expression of progenitor homeodomain proteins in E9.5 (A and A) and E10.5 (B–E and B–E) embryos heterozygous (A–E)
or homozygous (A–E) for the Ngn2KILacZ allele. At E10.5, there is a severe reduction in expression of both Pax6 (B and B) and Nkx2.2 (C and
C) in Ngn2 mutants, while expression of Nkx6.1 (D and D) and Irx3 (E and E) is not significantly affected. The reduction in Pax6 expression
is less pronounced at E9.5 (A and A).
Lim3, Hb9, and Isl1 mark three stages in the differenti- bryos carrying the Ngn2KILacZ null mutant allele. In mice
heterozygous for Ngn2KILacZ, anti--gal staining marksation of the somatic MN lineage. Lim3 is expressed in
dividing progenitors for V2 interneurons and MNs many cells in the MZ of the ventral spinal cord, and
double labeling for -gal and Isl1 showed that a large(Sharma et al., 1998; Tanabe et al., 1998), Hb9 is ex-
pressed in motor neuron progenitors and remains ex- fraction of these cells are MNs that express Isl1 (Figure
7I). In homozygous Ngn2KILacZ mutant embryos, -galpressed in early postmitotic neurons (Arber et al., 1999),
and Isl1 is first expressed in recently born MNs (Tanabe cells are present in normal number in the MZ of the
ventral spinal cord, and they appear to properly projectet al., 1998) (Figures 7D–7F). In the spinal cord of Ngn2
mutants at E10.5, the number of cells expressing Hb9 their axons to the ventral root, suggesting that in ab-
sence of Ngn2, MNs have conserved essential aspects(Figure 7E) and Isl1 (Figure 7F) was greatly reduced
(number of Isl1 cells at cranial level, mutants: 45.8  of their differentiation program (Figure 7I). However,
many -gal cells either do not express Isl1 or only19.4, controls: 91.6  23.7; at brachial level, mutants:
46.4  14.3, controls: 100.3  22.4. Mean values  SD). express it at low levels (Figure 7I), indicating that Ngn2
function is specifically required for the correct expres-The number of Lim3 cells was less severely affected,
although Lim3 expression was clearly disorganized (Fig- sion of Isl1, as well as other homeodomain proteins
participating to neuronal subtype-specific differentia-ure 7D). As with the expression of Pax6 reported above,
the reduction in Hb9 and Isl1 expression was somewhat tion programs.
variable, with five out of eight mutant embryos being
similarly affected and the other embryos showing a Redundancy between Ngn1 and Ngn2 in Regulation
of Ventral Spinal Cord Neurogenesismarked but less severe reduction (data not shown). The
reduction in Isl1 expression in the ventral spinal cord of The lack of an overt neurogenesis defect in the spinal
cord of Ngn2 mutant embryos, as shown by the normalNgn2 mutants was already apparent at E9.75 (number
of Isl1 cells at brachial level, mutants: 22.5  10.8, expression of the neuronal markers SCG10 and NF-M,
suggested that the loss of Ngn2 function may be partiallycontrols: 41.1  16.4) and was still apparent at E12.5
(number of Isl1 cells at brachial level, mutants: 31.2  compensated for by the activity of another proneural
gene. The closely related gene Ngn1 is expressed in the3.1, controls: 44.2  9.3).
The reduction in expression of interneuron and MN spinal cord with a pattern that largely overlaps that of
Ngn2 (Sommer et al., 1996), and Ngn1 and Ngn2 havemarkers in Ngn2 mutants could be due to a loss of
neuronal populations, to their abnormal specification, or been shown to be partially redundant for the generation
of sensory neurons in dorsal root ganglia (Ma et al.,to defects limited to the expression of several neuronal
subtype-specific homeodomain proteins. Expression of 1999). We thus addressed the possibility that Ngn1 pro-
motes spinal cord neurogenesis in absence of Ngn2 bythe neuronal markers SCG10 and neurofilament (155
kDa, NF-M) was not significantly affected in the Ngn2 examining the spinal cord of embryos double mutant
for Ngn1 and Ngn2 (Ma et al., 1999; Fode et al., 2000).mutant spinal cord (Figures 7G, 7G, 7H, and 7H), indi-
cating that loss of Ngn2 function does not lead to a Indeed, whereas SCG10 expression levels were not no-
ticeably affected in Ngn1 single mutants, expression ofgross reduction in the number of postmitotic neurons.
To further examine the fate of Ngn2 mutant progenitors, the gene was very much reduced in the MZ of the spinal
cord in Ngn1;Ngn2 double mutants, particularly at MNwe analyzed the distribution of the -gal protein in em-
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Figure 7. Ngn2 Is Required for the Correct
Expression of Neuronal Subtype-Specific Ho-
meodomain Proteins in the Spinal Cord
Immunocytochemistry for homeodomain
proteins in the brachial spinal cord of E10.5
embryos heterozygous (A–F) and homozy-
gous (A–F) for the Ngn2 null allele Ngn2KILacZ.
In the mutant spinal cord, expression of the
interneuron markers Lim12 (A), En1 (B), and
Chx10 (C) is reduced to a few cells (A–C).
Among MN markers, expression of Lim3 (D)
appears disorganized while that of Hb9 (E)
and Isl1 (F) is very much reduced, in both
number of expressing cells and levels of ex-
pression (E and F). Expression of the neu-
ronal markers SCG10 (G and G) and neuro-
filament (NF-M; H and H) in heterozygous (G
and H) and homozygous (G and H) mutant
embryos. There is no apparent reduction in
number of SCG10 and NF-M neurons pro-
duced in the Ngn2 mutant ventral spinal cord.
Merged images of immunocytochemistry for
-gal and for Isl1 in the same heterozygous
(I) and homozygous (I) Ngn2KILacZ mutant em-
bryos as in panels (F) and (F), respectively.
The reduction in MN marker expression is not
due to a loss of the progeny of Ngn2 MN
progenitors since a similar number of -gal
cells is found in embryos heterozygous (I) or
homozygous (I) for the Ngn2KILacZ allele. More-
over, mutant MNs project axons to the ventral
root (arrowheads in [H] and [I]). However,
while many ventral -gal cells express Isl1
in heterozygous embryos (I), a large fraction
of -gal cells do not express this MN marker
in homozygous mutants (I).
levels, indicating that the number of neurons born was observed in single mutant embryos. However, examina-
tion of Isl1 expression revealed that the differentiationconsiderably smaller (Figure 8A). Double mutant spi-
nal cords also had an enlarged ventricle, which was not of MNs was not significantly more affected in Ngn1;Ngn2
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Figure 8. Redundancy between Ngn1 and
Ngn2 in the Regulation of Ventral Spinal Cord
Neurogenesis
Expression of SCG10 marks post mitotic neu-
rons in the MZ of the spinal cord (A–A) and
shows that the production of post mitotic
neurons is greatly reduced in the ventral spi-
nal cord of E10.5 Ngn1; Ngn2 double mutant
embryos (A) compared to wild-type (A) and
single Ngn1 (A) and Ngn2 mutant (A) em-
bryos. In contrast, expression of Isl1 (B-B)
does not reveal a more severe defect in speci-
fication of MNs in double mutant embryos
(B) compared to single Ngn2 mutants (B).
Single Ngn1 mutant embryos do not present a
significant reduction in expression of Isl1 (B).
double mutants than in Ngn2 single mutants (Figures hancers that are active at different dorsoventral levels
and that depend to various degrees on Pax6 function.8B–8B and data not shown). These results indicate
that Ngn2 is required both for the generation of postmi- In the other direction, Ngn2 activity is itself required
for the proper expression of homeodomain proteins intotic neurons and for the correct expression of homeo-
domain proteins involved in neuronal subtype-specific progenitor domains and neuronal populations through-
out the ventral spinal cord. We discuss the significancedifferentiation programs in the ventral spinal cord. Inter-
estingly, Ngn1 compensates the loss of Ngn2 for the of the regulation by Pax6 of proneural gene expression,
and the role of Ngn2 in the differentiation of ventralinitiation of neurogenesis, but not for the regulation of
homeodomain protein expression. spinal cord neurons.
A Role for Pax6 in Regulating Ngn2 ExpressionDiscussion
The Ngn2 enhancers characterized in this study are ac-
tive in progenitor domains that are restricted along theIn this paper, we show that Ngn2, a bHLH gene with
proneural properties, is involved in crossregulatory in- DV axis of the spinal cord, suggesting that Ngn2 expres-
sion may be regulated by Shh-dependent pathways thatteractions with homeodomain proteins involved in neu-
ronal fate specification in the ventral spinal cord. In one establish the DV positional identity of ventral progeni-
tors. In support of this idea, the three Ngn2 enhancersdirection, Ngn2 expression is driven by distinct en-
Neuron
214
examined are dependent to various degrees on the func- ties (Jan and Jan, 1994; Brunet and Ghysen, 1999; Guille-
mot, 1999). However, there is currently little knowntion of Pax6, a gene repressed by Shh in the ventral
regarding the molecular mechanisms underlying thespinal cord (Ericson et al., 1997), for the establishment
ability of bHLH proteins to specify neuronal identities.of their distinct DV domains of activity. In the absence
In this paper, we show that Ngn2 is required for theof Pax6, the activity of these enhancers is reduced or
correct expression of a number of homeodomain pro-abolished in their normal domains, and is expanded to
teins expressed in ventral spinal cord progenitors (Pax6,ectopic sites. Loss of Ngn2 expression and loss of E3
Nkx2.2) and neurons (Lim1/2, En1, Chx10, Hb9, Isl1). Weenhancer activity in the dorsal spinal cord of Sey em-
have examined the phenotype of MNs to gain furtherbryos (Figure 5) is likely to reflect a function for Pax6
insights into Ngn2 function in the spinal cord. The MNin this region of the neural tube, where it is normally
defect in Ngn2 mutants differs from the respecificationexpressed at low levels (Figure 6B and data not shown).
of MNs observed in mutations previously shown to inter-Together, our data raise the intriguing possibility that
fere with MN development. For example, mutations inPax6 itself defines the DV position of Ngn2 enhancer
Pax6 and Nkx6.1 lead to a respecification of MNs into V3activity. Mechanistically, Ngn2 enhancers may directly
and V1 interneurons, respectively (Ericson et al., 1996;read Pax6 protein levels, such that each enhancer is
Osumi et al., 1997; Briscoe et al., 1999; Sander et al.,differentially activated along the DV axis by the graded
2000), while a mutation in Hb9 results in the transientconcentration of Pax6 protein. Alternatively, Pax6 could
acquisition by MNs of features of V2 interneurons (Arberfunction in a concentration-independent manner to acti-
et al., 1999; Thaler et al., 1999). In contrast, there is novate Ngn2 enhancers, with another mechanism de-
evidence that Ngn2 mutant MN progenitors, which dotermining the position of the enhancer domains. Further
give rise to postmitotic neurons as evidenced by thecharacterization of Ngn2 enhancer elements will be re-
expression of the neuronal markers SCG10 and neurofil-quired to distinguish between these hypotheses and to
ament, acquire an alternative interneuron fate, as ex-establish whether the regulation of Ngn2 by Pax6 is
pression levels of markers for interneurons of the V3direct or indirect. One important point to note is that
(Nkx2.2), V2 (Chx10), and V1 (En1) classes are reducedPax6 is not the only factor required for E2 and E3 en-
rather than ectopically expressed in the absence ofhancer activity in the spinal cord, suggesting that regula-
Ngn2. Other observations strongly suggest that the MNtion of Ngn2 is complex and likely involves several dis-
fate is maintained in the absence of Ngn2. In particular,tinct mechanisms.
Ngn2 mutant MNs project their axons to ventral roots,Although a dependence of Ngn2 expression on Pax6
and HB9 and Isl1 are expressed, albeit at very reducedfunction has been demonstrated in the cerebral cortex
levels, in many Ngn2 mutant MNs at E10.5. Thus, al-and the retina (Stoykova et al., 2000; Toresson et al.,
though the Ngn2 mutation results in an abnormal ex-2000; Yun et al., 2000; Marquardt et al., 2001), a similar
pression of MN-specific regulatory genes, this mutantinteraction has not yet been reported in the ventral spinal
phenotype argues against an instructive role for Ngn2cord. Prior to this study, the main function of Pax6 in the
in the specification of MN identity. This idea is furtherventral spinal cord was thought to be Nkx2.2 repression
supported by the observation that Ngn2 is expressed(Briscoe et al., 1999). Our data indicate that Pax6 is also
broadly in the ventral spinal cord, and its mutation af-involved in the specification and differentiation of spinal
fects other neuronal populations in addition to MNs,cord neurons through its regulation of Ngn2. This result,
including Lim1/2 dorsal interneurons and En1 andtogether with the previously reported regulation of Ngn3
Chx10 ventral interneurons.by Nkx2.2 (Briscoe et al., 1999), suggests that homeodo-
Therefore, rather than having a specific role in MN ormain proteins may regulate neuronal fate through the
interneuron fate specification, Ngn2 appears to be moreparallel activation of proneural bHLH genes and homeo-
generally required in different progenitor domains fordomain genes involved in the specification of neuronal
the expression of homeodomain proteins participating
phenotypes. Given that other bHLH genes are also ex-
in various subtype-specific programs of differentiation.
pressed in well-defined DV domains, it is possible that
This suggests that Ngn2 may act as a necessary but only
genetic pathways underlying neural tube patterning and permissive component of pathways specifying neuronal
neurogenesis are directly linked through crossregula- fates in the spinal cord. This function is clearly different
tory interactions between factors specifying the DV from that of bHLH genes in other tissues such as the
identity of progenitors and proneural bHLH factors retina, where mutations in Mash1, NeuroD, Math3, and
throughout the neural tube. Math5 all result in changes in ratios of the different
retinal cell types, suggestive of instructive roles for these
A Permissive Role for Ngn2 in Neuronal Fate genes in specification of neuronal identities (reviewed
Specification in the Spinal Cord in Cepko, 1999; Guillemot, 1999). Ngn2 is likely to work
The specification of neural progenitors involves the par- in spinal cord progenitors in combination with other
allel activation of several genetic programs—a program transcription factors with more restricted expression
of neurogenesis that controls the selection of neural patterns and having instructive roles in neuronal fate
progenitors and their commitment to differentiation, and specification. The regulation of the expression of deter-
a program specifying the identity of progenitors and minants of neuronal identities throughout the ventral
their neuronal phenotype. A great deal of evidence sup- spinal cord by Ngn2 may be important to integrate the
ports the idea that these genetic programs do not run process of neurogenesis with mechanisms specifying
independently. In particular, bHLH genes have been neuronal fate in the different progenitor domains. To
shown to participate in both the determination of a ge- further address the role of Ngn2 in specification of neu-
ronal identities and confirm that Ngn2 has a permissiveneric neural fate and the specification of neuronal identi-
Ngn2 and Homeodomain Genes in Ventral Neural Tube
215
rather than instructive role in this process will require ventral spinal cord. This result raises the interesting
question of why Ngn1 compensates only for a subsetto ectopically express Ngn2 in regions of the spinal cord
where it is not expressed. of the functions of Ngn2, i.e., the determination of pro-
genitors and not the regulation of homeodomain gene
expression. It is possible that Ngn1 and Ngn2 have intrin-Ngn2 Role in Maintaining Homeodomain Protein
sically different properties and regulate the expressionExpression in Progenitors
of distinct sets of target genes. Alternatively, differencesIn addition to the regulation of neuronal subtype deter-
in the temporal regulation of Ngn1 and Ngn2 expressionminants such as Hb9 and Isl1, Ngn2 is also required for
in the spinal cord (Sommer et al., 1996) may allow Ngn1the correct expression of Pax6 and Nkx2.2, two early
to activate a neurogenesis program, but not the expres-expressed homeodomain proteins involved in the speci-
sion of homeodomain proteins. Further examination offication of progenitor identity in the ventral spinal cord.
the expression and function of Ngn1 and Ngn2 in ventralWhat is the significance of the regulation of a patterning
progenitors will be necessary to address these issues.gene such as Pax6 by Ngn2? One possibility is that the
bHLH proteins play important roles in promoting thedifferent phases of Pax6 regulation reflect sequential
transitions between progenitor states, acting in a coordi-functions of Pax6 in spinal cord progenitors. For exam-
nated manner with environmental signals to control theple, in addition to its early function in specifying the
progression of neural lineages from stem cells to postmi-DV identity of neural tube progenitors (Ericson et al.,
totic neurons (Lo et al., 1997; Edlund and Jessell, 1999).1997; Osumi et al., 1997), Pax6 may have a later function
Further analysis of the function and regulation of Ngn2in specification of neuronal fates. Precedents exist
and other bHLH genes will shed more light on how thesewhereby paired-homeodomain genes function in cell
genes may act to synchronize genetic pathways thatfate specification. For example, Pox neuro specifies
specify neuronal identity with the progression of neuralpolyinnervated sense organs in Drosophila (Dambly-
lineage development.Chaudiere et al., 1992), and Pax6 and Pax4 are involved
in the development of pancreatic endocrine lineages
(Sander et al., 1997; Sosa-Pineda et al., 1997; St-Onge
Experimental Procedures
et al., 1997). Interestingly, Pax6 functions downstream
of Ngn3 in the pancreas (Gradwohl et al., 2000), and in Transgene Construction
Ngn2 genomic clones were isolated by screening a 129 Sv mousethe fly poxn expression requires the activity of the bHLH
library as previously described (Gradwohl et al., 1996). One clonegenes of the achaete-scute complex (Vervoort et al.,
contained a 16520 bp insert that included 792 bp of Ngn2 protein1995). Thus, a similar relationship between an upstream
coding sequence, 9238 bp of 5 sequence, and 6490 of 3 sequencebHLH gene involved in lineage determination and a
(Figure 1A). A comparison of this sequence with that of a Ngn2
downstream Pax-related gene involved in specifying cell cDNA (Gradwohl et al., 1996) revealed the presence of a 269 bp
identity is observed in the ventral spinal cord. intron located 270 bp in front of the start codon of Ngn2 (data not
shown). The E1-hsp and E1--globin transgenes contain a 1758 5The reduction of Pax6 expression can easily be ex-
bp NotI fragment cloned into the heterologous reporter constructsplained by a cell autonomous regulation of Pax6 by
hsp68lacZpA and BGZA, upstream of the basal promoters of theNgn2, either direct or indirect, as Ngn2 is expressed in
hsp68 or human -globin genes, respectively. The E2-LacZ trans-Pax6 progenitors. In contrast, the severe downregula-
gene construct contains a 7610 bp EagI fragment including 5-flank-
tion of Nkx2.2 expression in Ngn2 mutants must involve ing sequences and 144 bp of Ngn2 coding sequence. This fragment
a non-cell autonomous interaction, as Ngn2 is not ex- has been cloned into the pINL reporter vector (Fode et al., 2000),
upstream of the IRES sequence. The E2-GFP transgene containspressed in most Nkx2.2 cells. This phenotype sug-
the same 7610 bp fragment cloned into the pmMGFP plasmid (kindlygests that cellular interactions between Ngn2 cells and
provided by S. Hodge). The E3-hsp and E4-hsp constructs containNkx2.2 cells are necessary for the integrity of the latter.
two different and partially overlapping 3 sequences inserted down-Whether Ngn2 cells are required for the survival, prolif-
stream of the LacZ sequence in the hsp68lacZpA vector: a 2616 bp
eration, correct specification, and/or positioning of fragment from the Ngn2 3UTR (E3) and a 5216 bp BamHI fragment
Nkx2.2 cells will require further analysis of the cellular which overlaps with E3 over 1347 bp (E4). All fragments for injection
were separated from vector sequences in a 1% agarose gel, purifiedaspects of the Ngn2 mutant phenotype.
using Elutip columns (Schleicher & Schuel) and resuspended in
injection buffer (10 mM Tris-HCl [pH 8], 0.1 mM EDTA).Partial Redundancy between Ngn1 and Ngn2
Functions in the Ventral Spinal Cord
The spinal cord phenotype in Ngn2 mutants is in striking Generation and Genotyping of Transgenic and Mutant Mice
Transgenic mice were generated by standard procedures using fer-contrast with phenotypes resulting from the loss of
tilized eggs from FVBN embryos and founder animals were geno-proneural genes in other neural lineages, which are usu-
typed by PCR performed on genomic DNA extracted from yolk sacsally characterized by a loss of progenitor populations
or tails. Genotyping of the LacZ allele was performed with primers(see Introduction). For example, mutations in Ngn1 and
situated in the upper (CCAGCTGGCGTAATAGCGAA) and lower
Ngn2 result in a complete absence of cranial sensory (CGCCCGTTGCACCACAGATG) strands of the bacterial-galactosi-
neuron progenitors (Fode et al., 1998; Ma et al., 1998), dase sequence. PCR conditions for the LacZ allele were 30 cycles
of 94C/1 min; 60C/1 min; 72C/1 min. Founder animals were out-while a Mash1 mutation leads to the elimination of a
bred with CD1 animals for all studies.subset of ventral telencephalic progenitors (Casarosa
Mice heterozygous for the Ngn2KILacZ allele (Fode et al., 2000) wereet al., 1999). While neuronal production is grossly unaf-
intercrossed to generate homozygous mutant embryos. Mice het-fected in the ventral spinal cord of Ngn2 mutants, the
erozygous for the Ngn1 allele (kindly provided by D.J. Anderson)
number of neurons produced in Ngn1;Ngn2 double mu- were bred with the Ngn2KILacZ line and double heterozygous mice
tants is severely reduced, indicating that Ngn1 and Ngn2 were intercrossed to generate Ngn1;Ngn2 double homozygous mu-
tant embryos. PCR genotyping of Ngn1 (Ma et al., 1998) and Ngn2are redundant for the control of neurogenesis in the
Neuron
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mutant alleles (Fode et al., 2000) was performed as previously de- the gifts of cDNA clones and antibodies. The monoclonal antibodies
Pax6, 74.5A5, 40.2D6, 4G11, 81.5C10, and 67.4E12, developed byscribed.
Mice carrying the Sey mutation (kindly provided by A. Stoykova A. Kawakami, T.M. Jessell, and S. Brenner-Morton, were obtained
from the Developmental Studies Hybridoma Bank maintained byand P. Gruss) were bred with the different Ngn2 enhancer::LacZ
transgenic lines, and the Ngn2KILacZ line and double heterozygous the Iowa University, Department of Biological Sciences. R.S. was
supported by fellowships from the Italian Telethon Foundation andSey;LacZ positive animals were interbred to generate homozygous
Sey; heterozygous LacZ embryos. Homozygous Sey mutant em- the European Community TRM Program and C.S. by fellowships
from the Human Frontiers Science Program and Medical Researchbryos were identified by their eye phenotype and LacZ embryos by
X-gal activity. Council of Canada. Note the change of name from Carol Fode to
Carol Schuurmans. This work was supported by grants from the
European Commission Biotech Program, the Human Frontiers Sci--Galactosidase Staining of Embryos
ence Program, the Association pour la Recherche sur le Cancer,Staged transgenic embryos were dissected from the uterus in cold
the Association Franc¸aise contre les Myopathies, and the Ministe`rePBS and fixed in 25% glutaraldehyde for 15–30 min at room temper-
de l’Enseignement et de la Recherche to F.G. and by institutionalature. Whole-mount -gal staining was performed as described in
funds from INSERM, CNRS, and Hoˆpital Universitaire de Strasbourg.Beddington et al. (1989). For analysis of spinal cord sections, stained
embryos were embedded in agarose and vibratome sectioned at
100 m. Received November 27, 2000; revised May 1, 2001.
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